Literature DB >> 24025383

Prognostic factors associated with mortality before and during anti-tuberculosis treatment.

Y-F Yen1, M-Y Yen, H-C Shih, B-S Hu, B-L Ho, L-H Li, J-C Hsiao, C-Y Deng.   

Abstract

OBJECTIVE: To identify factors associated with death before the start of anti-tuberculosis treatment, and early and late during treatment, among adult Taiwanese with culture-positive pulmonary tuberculosis (PTB).
METHOD: All adult culture-positive PTB patients in Taipei, Taiwan, were included in a retrospective cohort study in 2005-2010.
RESULTS: Of 4438 patients (mean age 64.6 years, 70.6% male), 76.8% were successfully treated, 5.4% died before start of treatment, 9.0% died within 8 weeks of treatment initiation and 8.8% died >8 weeks after treatment initiation. After controlling for potential confounders, age ≥ 65 years and male sex were associated with higher risks of death at all time periods investigated. High school education or higher reduced the risk of death before the start of and during treatment, while unemployment increased the risk of mortality during treatment. Cavity on chest X-ray and positivity for acid-fast bacilli were associated with lower risk of mortality before the start of treatment.
CONCLUSION: To lower mortality among adult culture-positive PTB patients, it is imperative for clinicians to maintain high awareness of TB and provide more intensive care early, especially for men, the elderly and people with lower socio-economic status (e.g., the unemployed and less educated).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24025383     DOI: 10.5588/ijtld.12.0888

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Unemployment in TB patients - ten-year observation at regional center of pulmonology in Bydgoszcz, Poland.

Authors:  Grzegorz Przybylski; Anita Dabrowska; Marta Pilaczyńska-Cemel; Dorota Krawiecka
Journal:  Med Sci Monit       Date:  2014-11-02

2.  Is early tuberculosis death associated with increased tuberculosis transmission?

Authors:  Anu Parhar; Zhiwei Gao; Courtney Heffernan; Rabia Ahmed; Mary Lou Egedahl; Richard Long
Journal:  PLoS One       Date:  2015-01-26       Impact factor: 3.240

3.  High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.

Authors:  Aishatu L Adamu; Muktar A Gadanya; Isa S Abubakar; Abubakar M Jibo; Musa M Bello; Auwalu U Gajida; Musa M Babashani; Ibrahim Abubakar
Journal:  BMC Infect Dis       Date:  2017-02-23       Impact factor: 3.090

4.  Development and validation of a prognostic score during tuberculosis treatment.

Authors:  Eric Walter Pefura-Yone; Adamou Dodo Balkissou; Virginie Poka-Mayap; Hadja Koté Fatime-Abaicho; Patrick Thierry Enono-Edende; André Pascal Kengne
Journal:  BMC Infect Dis       Date:  2017-04-08       Impact factor: 3.090

5.  Association of Body Mass Index with Timing of Death during Tuberculosis Treatment.

Authors:  Hsin-Hao Lai; Yun-Ju Lai; Yung-Feng Yen
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

6.  Diagnostic implications and inpatient mortality related to tuberculosis at Jimma Medical Center, southwest Ethiopia.

Authors:  Wakjira Kebede; Esayas Kebede Gudina; Getu Balay; Gemeda Abebe
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-01-23

7.  Factors associated with mortality among patients with culture-positive pulmonary tuberculosis in the urban poor population of Osaka City, Japan.

Authors:  Akira Shimouchi; Yuko Tsuda; Jun Komukai; Kenji Matsumoto; Hideki Yoshida; Akihiro Ohkado
Journal:  Western Pac Surveill Response J       Date:  2021-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.